Free Trial

Bolt Biotherapeutics (BOLT) Earnings Date, Estimates & Call Transcripts

Bolt Biotherapeutics logo
$0.57 -0.06 (-9.59%)
(As of 11/15/2024 ET)

Bolt Biotherapeutics Latest Earnings Summary

Upcoming
Earnings Date
Mar. 20Estimated
Actual EPS
(Nov. 12)
-$0.40 Missed By -$0.04
Consensus EPS
(Nov. 12)
-$0.36

Bolt Biotherapeutics released Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.40, which missed the consensus estimate of -$0.36 by $0.04. Quarterly revenue was reported to be $1.14 million, above analysts' expectations of $1.02 million. With a trailing EPS of -$1.71, Bolt Biotherapeutics' earnings are expected to grow next year, from ($1.51) to ($1.00) per share.

BOLT Upcoming Earnings

Bolt Biotherapeutics' next earnings date is estimated for Thursday, March 20, 2025, based off prior year's reporting schedules.

Get Bolt Biotherapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bolt Biotherapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BOLT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BOLT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Bolt Biotherapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.47-$0.47-$0.47
Q2 20242-$0.51-$0.39-$0.45
Q3 20242-$0.38-$0.24-$0.31
Q4 20242-$0.34-$0.26-$0.30
FY 20247-$1.70-$1.36-$1.53
Q1 20251-$0.27-$0.27-$0.27
Q2 20251-$0.27-$0.27-$0.27
Q3 20251-$0.27-$0.27-$0.27
Q4 20251-$0.27-$0.27-$0.27
FY 20254($1.08)($1.08)($1.08)

Bolt Biotherapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/20/2025
(Estimated)
------- 
11/12/2024--$0.36-$0.40 -$0.04-$0.40$1.02M$1.14M
8/13/2024Q2 2024-$0.48-$0.56 -$0.08-$0.56$1.19M$1.28M
5/14/2024Q1 2024-$0.51-$0.28+$0.23-$0.28$2.63M$5.27M
3/21/2024Q4 2023-$0.47-$0.47--$0.47$1.97M$2.09M
11/9/2023Q3 2023-$0.49-$0.43+$0.06-$0.43$1.60M$2.53M
8/7/2023Q2 2023-$0.53-$0.48+$0.05-$0.48$1.69M$1.43M
5/11/2023Q1 2023-$0.49-$0.45+$0.04-$0.45$1.67M$1.83M
3/29/2023Q4 2022-$0.63-$0.53+$0.10-$0.53$1.71M$1.41M

Bolt Biotherapeutics Earnings - Frequently Asked Questions

Bolt Biotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based off last year's report dates. Learn more on BOLT's earnings history.

In the previous quarter, Bolt Biotherapeutics (NASDAQ:BOLT) missed the analysts' consensus estimate of ($0.36) by $0.04 with a reported earnings per share (EPS) of ($0.40). Learn more on analysts' earnings estimate vs. BOLT's actual earnings.

Bolt Biotherapeutics (NASDAQ:BOLT) has a recorded annual revenue of $7.88 million.

Bolt Biotherapeutics (NASDAQ:BOLT) has a recorded net income of -$69.20 million. BOLT has generated -$1.71 earnings per share over the last four quarters.

Bolt Biotherapeutics's earnings are expected to grow from ($1.52) per share to ($0.99) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:BOLT) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners